Leading the pack
We have a growing body of evidence on the health effects of GOS for adults. Scientific studies show that GOS provides a superior prebiotic effect1-5 and improvement in GI (Gastro-Intestinal) health6.
We are also researching lactose-derived complex carbohydrates called Human Milk Oligosaccharides (HMOs), to sow the seeds for future innovations in gut health and beyond, such as Biotis™ 2’FL-HMO (2’-Fucosyllactose).
Clinical research reveals that GOS:
- Significantly increases Bifidobacteria in the gut of healthy adults with regular consumption7
- Has a positive influence on constipation in adults, with increased defecation frequency and easier defecation8,9
- Reduces GI-symptoms, like bloating, flatulence, abdominal pain and urgency10
- Reduces GI-symptoms in IBS patients, with less bloating and pain11,12
- Alleviates GI-symptoms in IBS patients, whereas inulin-type fructans aggravate these6
- We’re proud that our GOS prebiotics are the most researched in the world. They’ve been extensively trialled and tested in the context of both Early Life Nutrition and Adult Nutrition, where we’ve thoroughly investigated its potential health benefits, including digestive health and immunity.
FrieslandCampina Ingredients is the world’s leading GOS expert and supplier, with our very own tried and tested supply chain. This means we have complete control of the quality of our GOS solutions and can ensure the highest standards every step of the way.
References:
1 Watson, D. et al. Selective carbohydrate utilization by lactobacilli and bifidobacteria. J. Appl. Microbiol. 1132–46 (2013).
2 Stiverson, J. et al.cA comparative evaluation of prebiotic oligosaccharides using in vitro cultures of infant fecal microbiome. Appl. Environ. Microbiol. 7388–7397 (2014).
3 Rada, V. et al. Growth of infant faecal bifidobacteria and clostridia on prebiotic oligosaccharides in in vitro conditions. Anaerobe 205–208 (2008).
4 Rycroft, C., Jones, M., Gibson, G. & Rastall, R. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 91,878–887 (2001).
5 Bouhnik, Y. et al. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans (2014).
6 Wilson, B., Rossi, M., Dimidi, E. & Whelan, K. Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: A systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 109, 1098–1111 (2019).
7 Walton, G. E. et al. A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. Br. J. Nutr. 107, 1466–75 (2012).
8 Teuri, U. & Korpela, R. Galacto-oligosaccharides relieve constipation in elderly people. Ann. Nutr. Metab. 42, 319–27 (1998).
9 Surakka, A. et al. Yoghurt containing galactooligosaccharides facilitates defecation among elderly subjects and selectively increases the number of Bifidobacteria. Int. J. Probiotics Prebiotics 4, 65–74 (2009).
10 Vulevic, J., Tzortzis, G., Juric, A. & Gibson, G. R. Effect of a prebiotic galactooligosaccharide mixture (B-GOS®) on Gastro-Intestinal symptoms in adults selected from a general population who suffer with bloating, abdominal pain, or flatulence. Neurogastroenterol. Motil. 30, (2018).
11 Huaman, J. W. et al. Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders. Gastroenterology 155, 1004–1007 (2018).
12 Silk, D. B. A., Davis, A., Vulevic, J., Tzortzis, G. & Gibson, G. R. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment. Pharmacol. Ther. 29, 508–18 (2009).